Cargando…

Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability

Cardiovascular disease (CVD) is the leading cause of death among men and women worldwide. In CVD, hypertension and dyslipidemia commonly coexist and are managed through coadministration of amlodipine and atorvastatin, respectively. The case for fixed-dose combination (FDC) oral dosage forms and oral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dennison, Thomas J, Smith, Julian C, Badhan, Raj K, Mohammed, Afzal R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358997/ https://www.ncbi.nlm.nih.gov/pubmed/28352156 http://dx.doi.org/10.2147/DDDT.S126035

Ejemplares similares

Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole
por: Kukulka, Michael, et al.
Publicado: (2016)

Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization
por: M. Tawfeek, Hesham, et al.
Publicado: (2020)

The Influence of Formulation and Manufacturing Process Parameters on the Characteristics of Lyophilized Orally Disintegrating Tablets
por: Jones, Rhys J., et al.
Publicado: (2011)

Formulation Design of Fast Disintegrating Tablets Using Disintegrant Blends
por: Shirsand, S. B., et al.
Publicado: (2010)

Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets
por: Chono, Sumio, et al.
Publicado: (2016)

Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet
por: Hesari, Zahra, et al.
Publicado: (2016)

Formulation and development of paediatric orally disintegrating carbamazepine tablets
por: Canadell-Heredia, R, et al.
Publicado: (2022)

Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets
por: Remya, KS, et al.
Publicado: (2010)

Natural Polymer Chitosan as Super Disintegrant in Fast Orally Disintegrating Meloxicam Tablets: Formulation and Evaluation
por: Draksiene, Gailute, et al.
Publicado: (2021)

Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet
por: Aslani, Abolfazl, et al.
Publicado: (2016)

Predicting oral disintegrating tablet formulations by neural network techniques
por: Han, Run, et al.
Publicado: (2018)

Design, Formulation and Physicochemical Evaluation of Dimenhydrinate Orally Disintegrating Tablets
por: Aslani, Abolfazl, et al.
Publicado: (2018)

Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets
por: Koner, Jasdip S., et al.
Publicado: (2019)

Investigation of Formulation and Process of Lyophilised Orally Disintegrating Tablet (ODT) Using Novel Amino Acid Combination
por: AlHusban, Farhan, et al.
Publicado: (2010)

Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets
por: Keny, R. V., et al.
Publicado: (2010)

Formulation and Evaluation of Mouth Disintegrating Tablets of Atenolol and Atorvastatin
por: Sarfraz, R. M., et al.
Publicado: (2015)

Efficacy, Safety, and Palatability of RACTAB® Formulation Amlodipine Orally Disintegrating Tablets
por: Fukui-Soubou, Mari, et al.
Publicado: (2012)

Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)
por: Chinwala, Maimoona
Publicado: (2020)

Oral Bioavailability and Pharmacokinetics of Sildenafil Orally Disintegrating Tablets under Various Gastric pH Levels Following Administration of Omeprazole in Rats
por: Shih, Chin-Yu, et al.
Publicado: (2023)

Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administration
por: Kukulka, Michael, et al.
Publicado: (2017)

Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet
por: Tayebi, Hoda, et al.
Publicado: (2011)

Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives
por: Ghourichay, Mohammadali Poursharifi, et al.
Publicado: (2021)

Effect of food thickener and jelly wafer on the pharmacokinetics of levofloxacin orally disintegrating tablets
por: Tomita, Takashi, et al.
Publicado: (2019)

Current opinions and recommendations of paediatric healthcare professionals – The importance of tablets: Emerging orally disintegrating versus traditional tablets
por: Alyami, Hamad, et al.
Publicado: (2018)

Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design
por: Soroush, Hadis, et al.
Publicado: (2018)

A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
por: Tawfik, Essam A., et al.
Publicado: (2021)

Formulation and evaluation of taste-masked oral disintegrating tablet containing tolterodine-loaded montmorillonite
por: Taymouri, Somayeh, et al.
Publicado: (2023)

Formulation Design and Optimization of Fast Disintegrating Lorazepam Tablets by Effervescent Method
por: Shirsand, S. B., et al.
Publicado: (2010)

Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations
por: Khan, Dilawar, et al.
Publicado: (2021)

Evidence-Based Nanoscopic and Molecular Framework for Excipient Functionality in Compressed Orally Disintegrating Tablets
por: Al-khattawi, Ali, et al.
Publicado: (2014)

Preparation and Evaluation of Directly Compressible Orally Disintegrating Tablets of Cannabidiol Formulated Using Liquisolid Technique
por: Limpongsa, Ekapol, et al.
Publicado: (2022)

Pharmaceutical Evaluation of Levofloxacin Orally Disintegrating Tablet Formulation Using Low Frequency Raman Spectroscopy
por: Yamamoto, Yoshihisa, et al.
Publicado: (2023)

Design of Experiments to Study the Impact of Process Parameters on Droplet Size and Development of Non-Invasive Imaging Techniques in Tablet Coating
por: Dennison, Thomas J., et al.
Publicado: (2016)

Formulation Development and Evaluation of Fast Disintegrating Tablets of Salbutamol Sulphate for Respiratory Disorders
por: Sharma, Deepak
Publicado: (2013)

Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men
por: Choi, Hyang-Ki, et al.
Publicado: (2016)

Development of Corn Starch-Neusilin UFL2 Conjugate as Tablet Superdisintegrant: Formulation and Evaluation of Fast Disintegrating Tablets
por: Juneja, Prateek, et al.
Publicado: (2014)

A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
por: Li, Feng-Qian, et al.
Publicado: (2011)

Formulation and In-vitro Evaluation of Orally Disintegrating Tablets of Olanzapine-2-Hydroxypropyl-β-Cyclodextrin Inclusion Complex
por: Ajit Shankarrao, Kulkarni, et al.
Publicado: (2010)

Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression
por: Tafere, Chernet, et al.
Publicado: (2021)

A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study
por: Teaima, Mahmoud H, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lm4udmih3tqs2379euh0q8mr7n